Yingying Hu

机构：Wenzhou Medical University, Wuhan University, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Hubei Provincial Center for Disease Control and Prevention, Wuhan Donghu University, Zhongnan Hospital of Wuhan University, Hi-Z Technology (United States), Shenzhen Technology University, Hubei University, Nanjing University · ORCID：0000-0002-4881-7517

发表论文 60 篇 · 总被引 1164 次 · h-index 18

代表论文

• The projections of global and regional rheumatic heart disease burden from 2020 to 2030 (2022 · Frontiers in Cardiovascular Medicine · 被引 47)
• Indole-3-propionic Acid Attenuates HI-Related Blood–Brain Barrier Injury in Neonatal Rats by Modulating the PXR Signaling Pathway (2022 · ACS Chemical Neuroscience · 被引 37)
• Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population (2023 · Atherosclerosis · 被引 21)
• A decision framework for Chinese-style cruise ship design based on informativeness weight method and group consensus reaching model (2024 · Advanced Engineering Informatics · 被引 19)
• Severe cytokine release syndrome induced by immune checkpoint inhibitors in cancer patients – A case report and review of the literature (2024 · Heliyon · 被引 18)
• Long-Term Exposure to Fine Particulate Constituents and Vascular Damage in a Population with Metabolic Abnormality in China (2023 · Journal of Atherosclerosis and Thrombosis · 被引 14)